科华生物 (002022.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(科华生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 2,428,075,213.951,904,222,528.931,396,475,774.51833,147,693.696,969,862,627.721,579,423,235.68902,928,251.87420,497,071.93
 营业利润(元) -179,327,353.0879,198,475.64106,193,677.56117,086,114.102,065,197,575.6384,267,432.4984,339,818.9839,592,381.31
 利润总额(元) -185,608,835.1075,266,249.30104,402,252.74116,345,639.982,065,181,885.6683,856,212.0784,091,683.8839,610,183.68
 净利润(元) -176,985,109.5048,569,569.9077,803,935.5497,174,299.351,731,370,056.0163,150,001.1066,234,684.2431,804,960.30
 归属于母公司股东的净利润(元) -234,014,886.40-19,954,130.6721,128,073.9254,761,876.98970,845,080.0236,851,184.8546,430,948.6122,283,233.48
盈利能力:
 销售毛利率(%) 42.3544.4045.3846.8852.5657.0043.2843.95
 销售净利率(%) -7.292.555.5711.6624.8435.897.347.56
 净资产收益率(%) -5.21-0.490.511.27----
 总资产报酬率ROA(%) -2.211.351.661.96----
 投入资本回报率ROIC(%) -4.32-0.360.370.9418.7122.520.990.48
营运能力:
 存货周转率(次) 1.251.220.860.50----
 应收账款周转率(次) 2.022.241.590.93----
 总资产周转率(次) 0.310.310.220.13----
偿债能力:
 资产负债率(%) 26.7925.7626.9828.4333.6023.4223.7422.75
 股东权益比率(%) 61.2862.5160.9660.5154.6371.3271.1171.71
 已获利息倍数(倍) -13.6410.5664.049.15-24.773.985.235.42
 流动比率 4.785.214.684.133.144.384.114.65
 速动比率 3.513.753.423.152.452.592.212.59
发展能力:
 营业收入增长率(%) -65.16-64.6254.6698.1343.5844.40-62.38-71.06
 营业利润增长率(%) -108.68-96.5225.91195.7325.8166.07-90.59-93.76
 税后利润增长率(%) -124.09-101.67-54.50145.7514.1663.50-90.31-93.49
 净资产增长率(%) -13.36-12.5320.6728.9424.3433.957.328.65
 总资产增长率(%) -22.81-23.1540.7452.8026.7141.21-12.63-18.12

前瞻产业研究院